Skip to main content
Wiley Open Access Collection logoLink to Wiley Open Access Collection
. 2026 Mar 23;66(1):e70046. doi: 10.1002/cga.70046

Clinical Diversity in Currarino Syndrome: Insights From Monozygotic Twins and a Single‐Center Retrospective Study

Xinyao Wang 1, Lingzhao Min 1, Lei Bao 2, Jia Wei 1, Xiaoqiang Wang 1,✉
PMCID: PMC13422656  PMID: 41871837

ABSTRACT

Currarino syndrome (CS) is a congenital disorder caused by MNX1 gene mutation, resulting in abnormal caudal cell mass development. Clinical presentation varies from severe to mild forms. Classic triad of CS includes sacral agenesis, presacral mass, and anorectal malformation (ARM). We report a pair of monozygotic twins, both with the MNX1: c.780C>G mutation, presenting with different clinical phenotypes of Currarino syndrome (CS). Both were suspected of anorectal atresia in utero, and postnatal diagnosis confirmed CS with tethered cord syndrome (TCS). They underwent staged surgeries, with normal growth at 10 months follow‐up. Additionally, a retrospective analysis of 95 CS cases diagnosed between April 2010 and April 2024 at Shanghai Xinhua Hospital was performed. Clinical, imaging, and pathological data were collected, and binary logistic regression was used to analyze the correlation between clinical factors and TCS. A literature review of twin CS cases was also conducted. Of the 95 patients, 23.2% had complete CS, and 76.8% had incomplete CS. TCS was present in 55.8% of cases. Logistic regression showed no significant correlation between age, sex, sacral deformity severity, ARM type, presacral mass, and TCS. Two previous twin CS cases were identified, both with differing phenotypes. CS exhibits phenotypic variability, and monozygotic twins with the same MNX1 mutation may present with different severities. The MNX1: c.780C>G mutation broadens the genetic spectrum of CS. TCS is common, emphasizing the need for multidisciplinary management. Surgical approaches should be personalized based on presentation.

Keywords: anorectal malformation, Currarino syndrome, MNX1, tethered cord syndrome, twin

1. Introduction

Currarino syndrome (CS) is a congenital malformation disorder caused by abnormal development of the tailbud, predominantly affecting males. The classic presentation of CS includes sacrococcygeal dysgenesis, a presacral mass, and anorectal malformations (ARM), known as the Currarino triad [1]. However, CS shows considerable phenotypic variability. Martucciello et al. classified CS into three types: complete (the classic triad), mild (sacral malformation with ARM or presacral mass), and minimal (only sacral malformation) [2]. CS may also be associated with other system malformations. In 1998, Ross et al. identified MNX1 gene mutations as the cause of this autosomal dominant condition [3], with variable phenotypic expression, possibly influenced by mutation type and other regulatory factors.

To date, two cases of monozygotic twins with CS have been reported, both of familial inheritance [4, 5]. We present a case of monozygotic twins with a newly identified missense mutation in the MNX1 gene and review CS patients treated at our hospital from January 2010 to April 2024, summarizing clinical features and phenotypic differences to enhance understanding of diagnosis and treatment.

2. Case Report

The patients are naturally conceived monozygotic twins, presenting at 8 months of age. A 28‐week four‐dimensional ultrasound showed no “target sign” in either twin, raising suspicion of anorectal malformation. Amniocentesis with whole‐exome sequencing revealed a de novo missense variant in MNX1 (NM_005515: c.780C>G, p.Pro260Arg). The mother took 400 μg of folic acid daily from preconception through delivery (the recommended dose for single pregnancies), with no exposure to teratogenic drugs or radiation and no history of abnormal blood glucose or other diseases.

The twins were delivered prematurely via cesarean section at 35 + five weeks due to unstable fetal heart rate. The birth weights were 2300 g for the older twin and 1800 g for the younger twin. The younger twin developed severe anemia, requiring NICU care. No anorectal malformation was detected at birth, and both twins passed meconium within 72 h. Currently, both twins have normal stool frequency and consistency, but the older twin shows significant developmental delay in gross motor skills, unable to roll over or sit independently.

Upon admission, the twins were jointly managed by neurosurgery and general surgery. Rectal examination revealed anal stenosis in the older twin, allowing only the fingertip to pass, with no palpable presacral mass. The younger twin had an anal opening allowing the insertion of one finger, with a soft mass felt in the rectal posterior. No significant abnormalities were found in the twins' neurological exams. Alpha‐fetoprotein levels were elevated, likely due to age. Lower gastrointestinal contrast imaging showed anal stenosis and rectal dilatation in the older twin, while no significant narrowing was seen in the younger twin. Sacrococcygeal MRI in both twins showed partial sacral defect, absent coccyx, lipoma extending into the sacral canal, a slightly widened sacral canal, and a presacral meningocele, with a slightly dilated central spinal canal, suggesting a possible diagnosis of tethered cord syndrome (Figure 1).

FIGURE 1.

FIGURE 1

Spinal MRI of twins. The T1WI sequence of the older child (A) shows a low‐lying conus medullaris with a presacral lipoma (red arrow) partially extending into the sacral canal. The T2WI sequence (B) shows a presacral meningocele (green arrow) and dilatation of the central canal of the spinal cord. The T1WI sequence of the younger child (C) also shows a low‐lying conus medullaris with a presacral lipoma (red arrow) partially extending into the sacral canal. The T2WI sequence (D) shows a slight presacral meningocele (green arrow).

Both twins subsequently underwent tethered cord release surgery, with the younger twin also receiving excision of the presacral mass. Pathology confirmed the mass as a lipoma. The older twin underwent excision of the presacral mass and anorectal reconstruction one month later, after completing bowel preparation. During the anorectal reconstruction, the examination revealed an anal opening at the anal dimple with no anal folds, and the anal canal appeared scarred and narrowed, measuring approximately 0.5 cm in length. An 8 Fr dilator (10.0 mm in diameter) could be passed preoperatively, while a 12 Fr dilator (14.0 mm in diameter) could be passed postoperatively. The postoperative pathology also confirmed lipoma. The child continued to use a dilator for anal dilation after the surgery.

At the 10‐month postoperative follow‐up, both twins showed normal growth, with no issues related to bowel or urinary control.

3. Materials and Methods

A retrospective analysis was conducted on the medical history and imaging data of 95 children with CS treated at Xinhua Hospital affiliated to Shanghai Jiao Tong University School of Medicine, between April 2010 and April 2024. Inclusion criteria were: children diagnosed with CS (including complete, mild, and minimal forms) based on clinical presentation, physical examination, imaging studies (including lower gastrointestinal contrast, X‐rays, CT, MRI), intraoperative findings, and postoperative pathology, with complete clinical history and imaging data, who underwent surgical treatment and outpatient follow‐up at our hospital. Exclusion criteria were: patients not diagnosed with CS, those with incomplete clinical data, or those who could not provide sufficient imaging data. Based on clinical presentation and imaging results, the children were divided into complete type and incomplete type (including mild and minimal forms). According to the Krickenbeck classification [6] ARM cases were classified into three groups: anal atresia with fistulas, anal atresia without fistulas, and anal stenosis. Based on MRI and intraoperative findings, the children were further divided into two groups: those with associated tethered cord syndrome (TCS and those without TCS. A telephone follow‐up was conducted for all patients, and those lost to follow‐up were excluded). Based on the results, patients were divided into two groups: one group with no excretory dysfunction (including both bowel and bladder functions) and another group with excretory dysfunction, which includes bowel dysfunction (e.g., fecal impaction, incomplete evacuation, constipation, fecal incontinence) and/or bladder dysfunction (e.g., urinary retention, urinary incontinence). Binary logistic regression analysis was performed using SPSS 27.0 to assess the correlation between CS with TCS and factors such as age, sex, sacrococcygeal malformation severity, anorectal malformation classification, presacral meningocele presence, and the presence of other associated malformations. Additionally, the same method was used to evaluate the impact of factors such as age, sex, CS classification, sacrococcygeal malformation severity, anorectal malformation classification, presacral meningocele presence, the presence of other associated malformations, and TCS surgical treatment on prognosis. A p‐value of less than 0.05 was considered statistically significant.

4. Results

A total of 95 children with CS were included in this study (Table 1), among which 22 cases (23.2%) were classified as complete type and 73 cases (76.8%) as incomplete type. Of all these patients, 80 children (84.2%) were diagnosed with ARM, including 57 cases with fistulas, 14 cases without fistulas, and 9 cases with anal stenosis. A total of 34 children (35.8%) had different pathological types of sacrococcygeal tumors (Table 2). Furthermore, 53 children (55.8%) were diagnosed with TCS, with 33 of these cases receiving surgical treatment at our hospital. Among the incomplete type patients, 58 cases had varying degrees of sacrococcygeal dysgenesis associated with ARM, including 1 case of anal stenosis, 12 cases without fistula, and 45 cases with fistula. Additionally, 12 incomplete type patients had varying degrees of sacrococcygeal dysgenesis associated with different pathological types of presacral masses. The age range of the children was 0 to 108 months, with 68 cases (71.6%) diagnosed with CS at birth. In terms of gender, 53 were male (55.8%) and 42 were female (44.2%). A total of 52 cases (54.7%) had associated TCS, with 36 cases in the complete type.

TABLE 1.

Basic characteristics of 95 CS patients.

No tethered cord syndrome With tethered cord syndrome
Age at First Diagnosis (months), Mean (±SD) 0.59 ± 2.582 5.05 ± 18.052
Gender (Male/Female) 29/13 (54.7%/31.0%) 24/29 (45.3%/69.0%)
Department at First Diagnosis
Pediatric Surgery 40 (51.9%) 37 (48.1%)
Pediatric Neurosurgery 0 (0.0%) 12 (100%)
Other Departments 2 (33.3%) 4 (66.7%)
Symptoms at Onset
Asymptomatic 35 (46.7%) 40 (53.3%)
Meconium not passed 3 (60.0%) 2 (40.0%)
Constipation 3 (37.5%) 5 (62.5%)
Constipation + Sacrococcygeal Pain 0 (0.0%) 1 (100%)
Urinary Incontinence 0 (0.0%) 1 (100%)
Constipation + Urinary Incontinence 0 (0.0%) 1 (100%)
Urinary/Fecal Incontinence 1 (100%) 0 (0.0%)
Sacral Presacral Mass Infection 0 (0.0%) 3 (100%)
CS Classification
Complete Type 9 (40.9%) 13 (59.1%)
Incomplete Type 34 (46.6%) 39 (53.4%)
Sacrococcygeal Malformation
Coccygeal Agenesis 16 (51.6%) 15 (48.4%)
Hemisacrum 7 (31.8%) 15 (68.2%)
Partial Sacral Agenesis 19 (45.2%) 23 (54.8%)
Anorectal Malformation
None 2 (13.3%) 13 (86.7%)
Annal stenosis 1 (11.1%) 8 (88.9%)
Non‐Fistula 5 (35.7%) 9 (64.3%)
Fistula 34 (59.6%) 23 (40.4%)
Presence of Meningocele
No 42 (50.0%) 42 (50.0%)
Yes 0 (0.0%) 11 (100%)
Urogenital Malformations
None 35 (44.3%) 44 (55.7%)
Upper Urinary Tract Malformation a 5 (45.5%) 6 (54.5%)
Lower Urinary Tract Malformation b 1 (50.0%) 1 (50.0%)
Upper + Lower Urinary Tract Malformation 1 (33.3%) 2 (66.7%)
Reproductive System Malformations
None 39 (43.3%) 51 (56.7%)
Uterus Didelphys 1 (33.3%) 2 (66.7%)
Cryptorchidism 2 (100%) 0 (0.0%)
Bone and Joint Malformations c
None 39 (43.3%) 51 (56.7%)
Present 3 (60.0%) 2 (40.0%)
Other Malformations
None 41 (44.1%) 52 (55.9%)
Ventricular Septal Defect 0 (0.0%) 1 (100%)
Esophageal Atresia 1 (100%) 0 (0.0%)
a

Upper urinary tract malformations: renal malrotation, hydronephrosis, renal dysplasia, ectopic kidney, horseshoe kidney, renal agenesis, vesicoureteral reflux.

b

Lower urinary tract malformations: hypospadias.

c

Bone and joint malformations: polydactyly, syndactyly, joint contractures, clubfoot.

TABLE 2.

Types of Presacral masses (34 cases).

Type N (%)
Lipoma 12 (35.3%)
Teratoma 6 (17.6%)
Epidermoid Cyst 1 (2.9%)
Dermoid Cyst 2 (5.9%)
Hemangioma 1 (2.9%)
Enteric Cyst 1 (2.9%)
Meningocele 3 (8.8%)
Meningocele + X
Lipoma 6 (17.6%)
Teratoma 1 (2.9%)
Dermoid Cyst 1 (2.9%)
Total 34 (100.0%)

Binary logistic regression analysis did not identify any significant statistical associations. The p‐values for all independent variables were greater than 0.05, indicating that factors such as age, sex, sacrococcygeal malformation severity, ARM classification, presacral meningocele presence, and the presence of other associated malformations did not show significant correlations with CS associated with TCS.

The telephone follow‐up yielded prognostic data for 82 children, with follow‐up durations ranging from 22.57 months to 190.23 months, and an average follow‐up period of 84.02 (±41.74) months. Among the patients, 53 (64.6%) had no excretory dysfunction, 6 (7.3%) had both bowel and bladder dysfunction, 20 (24.4%) had isolated bowel dysfunction, and 3 (3.7%) had isolated bladder dysfunction.

Binary logistic regression analysis revealed that the only significant factor affecting prognosis was whether the patient underwent TCS surgery (p = 0.017, OR = 0.35), suggesting that TCS release surgery can improve prognosis. Factors such as age, sex, sacrococcygeal malformation severity, ARM classification, presacral meningocele presence, and the presence of other associated malformations were not found to have a significant effect on prognosis.

5. Discussion

CS is caused by incomplete development of the caudal cell mass, leading to symptoms involving the spine, nerves, and gastrointestinal tract. The classic triad includes a presacral mass, sacral malformation, and anorectal malformation [1]. CS shows significant phenotypic variability, with Martucciello et al. classifying it into complete, mild, and minimal types [2]. Minimal type patients, if not associated with other malformations, often lack distinct clinical features and are usually undiagnosed. In this study, only two of 95 patients were minimal type.

Sacral malformations exhibit diverse phenotypes, ranging from partial sacral agenesis, hemisacrum, to coccygeal agenesis [2, 7]. Anorectal malformations also vary in phenotype and classification. According to the Krickenbeck classification, they can be divided into types with and without fistulas [6]. Among presacral masses, sacral meningocele is the most common, while in respectable solid presacral masses, dermoid cysts are most common. In this study, however, lipomas were most prevalent (35.3%, with three cases coexisting with sacral meningocele) [8]. Other reported pathologies include enteric cysts, rectal duplications, teratomas, epidermoid cysts, lipomas, and hamartomas. CS patients may also have neurological malformations, with TCS being the most common. In this study, 54.7% of patients had TCS, and 51.4% of complete‐type CS patients had TCS, lower than the 70.5% reported in previous literature (17 cases) [9]. Other neurological anomalies include filum terminale thickening, syringomyelia, intraspinal lipomas, hydrocephalus, and microcephaly. Additionally, urogenital malformations may be present, including horseshoe kidney, ectopic kidney, polycystic kidney, neurogenic bladder, vesicoureteral reflux, and uterovaginal duplication [1, 8, 9, 10, 11, 12, 13].

Anorectal atresia, sacral dysplasia, and presacral masses can be detected by prenatal ultrasound, or sacrococcygeal deformities may be noticed after birth. Late‐diagnosed patients often present with persistent constipation, which may be related to anorectal stenosis, presacral mass compression, nerve traction, or anorectal neurodevelopmental abnormalities [1, 2, 8]. Some children present with urinary dysfunction, potentially linked to tethered cord, presacral mass compression, or neurodevelopmental issues [14, 15]. When an anorectal fistula communicates with the central nervous system, central nervous system infections may occur [10]. Other severe complications include presacral mass abscesses, urinary tract infections, and rare malignant transformation of teratomas [8, 9, 16].

CS is an autosomal dominant genetic disorder caused by mutations in the MNX1 gene (formerly HLXB9) [3], which encodes a 403‐amino acid protein with a homeodomain. The mutation is found in nearly all familial cases and 30% of sporadic cases [7]. The patient in this case carries the MNX1: c.780C>G mutation, which has not been previously reported in the HGMD database for CS‐related mutations.

The two patients in this case are monozygotic twins. A search of PubMed revealed two previous reports of twin cases with CS (Table 3), both with family history, whereas in our case, both parents lacked gene mutations and phenotypic features, indicating a de novo mutation. Gobbi D et al. [4] reported a pair of dizygotic twins, both with complete‐type CS; one had left hydronephrosis, and the other had tethered cord (without undergoing tethered cord release surgery). Patel RV et al. [5] reported a pair of monozygotic twins with the same MNX1 gene mutation, one with complete‐type CS and the other with mild‐type CS (only partial sacral agenesis); both had TCS and underwent tethered cord release surgery. In our case, the monozygotic twins had the same MNX1 mutation, with one having complete‐type CS and the other mild‐type CS (partial sacral agenesis with a presacral mass), both with TCS. Previous studies have not found a correlation between mutation type and phenotype severity [7, 17]. Even within the same family with the same mutation, patients may present with varying degrees of phenotype severity, possibly related to epigenetic mechanisms [4].

TABLE 3.

Clinical features of twin CS cases reported in the literature [4, 5].

Case Type Gestational age (w) Diagnosis time Mutation source/Mutation site Gender Clinical symptoms Phenotype Treatment
Gobbi D et al. [4] Dizygotic 36 + 2 After birth Father/NA Male Neonatal low bowel obstruction Anorectal stenosis, Presacral mass (teratoma), Hemisacrum, Left hydronephrosis
  1. a Colostomy.

  2. Anorectal reconstruction + b Presacral meningocele and teratoma resection.

  3. Closure of colostomy

Father/NA Female Neonatal low bowel obstruction Anorectal stenosis, Presacral mass (presacral meningocele + teratoma), Partial sacral agenesis, TCS
  1. Colostomy.

  2. Anorectal reconstruction + Presacral meningocele and teratoma resection.

  3. Closure of colostomy

Patel RV et al. [5] Monozygotic 34 + 4 19 weeks gestation Mother/MNX1: c.234delG Male Asymptomatic Anorectal stenosis, Presacral meningocele, Partial sacral agenesis, TCS Anorectal reconstruction + Tethered cord release
Asymptomatic Anorectal stenosis, Partial sacral agenesis, TCS Tethered cord release
Our case Monozygotic 35 + 5 28 weeks gestation De novo/MNX1: c.780C>G Male Asymptomatic Anorectal stenosis, Presacral mass (presacral meningocele + lipoma), Partial sacral agenesis, TCS
  1. Tethered cord release.

  2. Presacral mass resection/Anorectal reconstruction

Asymptomatic Presacral mass (presacral meningocele + lipoma), Partial sacral agenesis, TCS Tethered cord release + Presacral mass resection
a

Represents staged surgery.

b

Represents multiple surgeries performed simultaneously.

The treatment of CS patients requires a multidisciplinary approach involving pediatric surgery, neurosurgery, and rehabilitation. The surgical approach and sequence depend on the patient's phenotype and severity. In this case, to avoid secondary anesthesia and reduce hospital stay, the younger twin underwent simultaneous excision of the mass and tethered cord release, while the older twin, with associated anorectal malformation, underwent a staged surgery. For structural abnormalities such as lipomas, presacral meningeal hernias, or possible tethered cord, conservative treatment with dynamic follow‐up can be considered if there are no clinical symptoms [9]. Severe anorectal malformations with defecation disorders should be addressed surgically first. Low anorectal malformations may be managed with a single‐stage surgery, while others often require a colostomy followed by a second‐stage anorectal reconstruction. When the patient has a presacral meningocele, meningocele resection and repair should be performed first, followed by anorectal reconstruction to reduce the risk of meningitis [15, 18]. Other types of presacral masses may be corrected concurrently with anorectal reconstruction. Tethered cord release can be performed with meningocele resection, while isolated tethered cord surgery timing depends on the severity of related symptoms (e.g., constipation, urinary difficulties, lower limb sensory or motor abnormalities) [19].

In some patients, constipation symptoms may not completely resolve after surgery, possibly due to anorectal neurodevelopmental abnormalities [2]. One study found that while urinary difficulties may persist in patients with tethered cord after detethering surgery, urodynamic results may improve [14].

6. Conclusion

CS is a congenital genetic disorder with phenotypic variability, where clinical manifestations can differ even with the same MNX1 mutation. The novel MNX1: c.780C>G mutation identified in this study expands the genetic spectrum of CS. CS is often associated with other abnormalities, and over half of patients have TCS, requiring multidisciplinary management, including pediatric surgery, neurosurgery, and rehabilitation. While surgery improves most symptoms, some patients may still experience long‐term developmental and bowel issues. The decision to undergo TCS release surgery is the primary factor influencing the prognosis of CS.

Funding

The authors have nothing to report.

Ethics Statement

This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Xinhua Hospital (Approval No. XHEC‐D‐2023‐002).

Conflicts of Interest

The authors declare no conflicts of interest.

Acknowledgments

We would like to express our sincere gratitude to Dr. Hai‐Bo Zhang from the Pediatric Neurosurgery Department of Xinhua Hospital for his comprehensive and selfless guidance in the preparation of this manuscript. Our thanks also go to Senior Brother Yang Liu from the Pediatric Urology Department of Xinhua Hospital for his understanding of the author's clinical work being affected due to time spent on writing.

Data Availability Statement

The data that support the findings of this study are available from the corresponding author upon reasonable request.

References

  • 1. Currarino G., Coln D., and Votteler T., “Triad of Anorectal, Sacral, and Presacral Anomalies,” American Journal of Roentgenology 137, no. 2 (1981): 395–398. [DOI] [PubMed] [Google Scholar]
  • 2. Martucciello G., Torre M., Belloni E., et al., “Currarino Syndrome: Proposal of a Diagnostic and Therapeutic Protocol,” Journal of Pediatric Surgery 39, no. 9 (2004): 1305–1311. [DOI] [PubMed] [Google Scholar]
  • 3. Ross A. J., Ruiz‐Perez V., Wang Y., et al., “A Homeobox Gene, HLXB9, Is the Major Locus for Dominantly Inherited Sacral Agenesis,” Nature Genetics 20, no. 4 (1998): 358–361. [DOI] [PubMed] [Google Scholar]
  • 4. Gobbi D., Zanatta C., Zanarotti R., Trincia E., and Midrio P., “Currarino Syndrome in Homozygous Twins Detected by Following Ultrasound During the Fetal Period,” Pediatrics International: Official Journal of the Japan Pediatric Society 63, no. 9 (2021): 1131–1133. [DOI] [PubMed] [Google Scholar]
  • 5. Patel R. V., De Coppi P., Kiely E., and Pierro A., “Currarino's Syndrome in Twins Presenting as Neonatal Intestinal Obstruction—Identical Presentation in Non‐Identical Twins,” BMJ Case Reports 2014 (2014): bcr2014204276. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Holschneider A., Hutson J., Peña A., et al., “Preliminary Report on the International Conference for the Development of Standards for the Treatment of Anorectal Malformations,” Journal of Pediatric Surgery 40, no. 10 (2005): 1521–1526. [DOI] [PubMed] [Google Scholar]
  • 7. Merello E., De Marco P., Ravegnani M., Riccipetitoni G., Cama A., and Capra V., “Novel MNX1 Mutations and Clinical Analysis of Familial and Sporadic Currarino Cases,” European Journal of Medical Genetics 56, no. 12 (2013): 648–654. [DOI] [PubMed] [Google Scholar]
  • 8. Caro‐Domínguez P., Bass J., and Hurteau‐Miller J., “Currarino Syndrome in a Fetus, Infant, Child, and Adolescent: Spectrum of Clinical Presentations and Imaging Findings,” Canadian Association of Radiologists Journal 68, no. 1 (2017): 90–95. [DOI] [PubMed] [Google Scholar]
  • 9. AbouZeid A. A., Mohammad S. A., Abolfotoh M., Radwan A. B., Ismail M. M. E., and Hassan T. A., “The Currarino Triad: What Pediatric Surgeons Need to Know,” Journal of Pediatric Surgery 52, no. 8 (2017): 1260–1268. [DOI] [PubMed] [Google Scholar]
  • 10. Saway B. F., Rafka H. E., Gunasekaran A., Porto G. B. F., and Varma A., “Surgical Management of Currarino Syndrome in Elderly Patient With Infected Pre‐Sacral Mass: Technical Nuances and Review of Literature,” Clinical Neurology and Neurosurgery 222 (2022): 107470. [DOI] [PubMed] [Google Scholar]
  • 11. Riebel T., Mäurer J., Teichgräber U. K., and Bassir C., “The Spectrum of Imaging in Currarino Triad,” European Radiology 9, no. 7 (1999): 1348–1353. [DOI] [PubMed] [Google Scholar]
  • 12. Köchling J., Pistor G., Märzhäuser Brands S., Nasir R., and Lanksch W. R., “The Currarino Syndrome—Hereditary Transmitted Syndrome of Anorectal, Sacral and Presacral Anomalies. Case Report and Review of the Literature,” European Journal of Pediatric Surgery: Official Journal of Austrian Association of Pediatric Surgery 6, no. 2 (1996): 114–119. [DOI] [PubMed] [Google Scholar]
  • 13. Cococcioni L., Paccagnini S., Pozzi E., et al., “Currarino Syndrome and Microcephaly due to a Rare 7q36.2 Microdeletion: A Case Report,” Italian Journal of Pediatrics 44, no. 1 (2018): 59. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Lee N. G., Gana R., Borer J. G., Estrada C. R., Khoshbin S., and Bauer S. B., “Urodynamic Findings in Patients With Currarino Syndrome,” Journal of Urology 187, no. 6 (2012): 2195–2200. [DOI] [PubMed] [Google Scholar]
  • 15. Cearns M. D., Hettige S., De Coppi P., and Thompson D. N. P., “Currarino Syndrome: Repair of the Dysraphic Anomalies and Resection of the Presacral Mass in a Combined Neurosurgical and General Surgical Approach,” Journal of Neurosurgery. Pediatrics 22, no. 5 (2018): 584–590. [DOI] [PubMed] [Google Scholar]
  • 16. Tander B., Baskin D., and Bulut M., “A Case of Incomplete Currarino Triad With Malignant Transformation,” Pediatric Surgery International 15, no. 5–6 (1999): 409–410. [DOI] [PubMed] [Google Scholar]
  • 17. Crétolle C., Pelet A., Sanlaville D., et al., “Spectrum of HLXB9 Gene Mutations in Currarino Syndrome and Genotype‐Phenotype Correlation,” Human Mutation 29, no. 7 (2008): 903–910. [DOI] [PubMed] [Google Scholar]
  • 18. Ilhan H., Tokar B., Atasoy M. A., and Kulali A., “Diagnostic Steps and Staged Operative Approach in Currarino's Triad: A Case Report and Review of the Literature,” Child's Nervous System: ChNS: Official Journal of the International Society for Pediatric Neurosurgery 16, no. 8 (2000): 522–524. [DOI] [PubMed] [Google Scholar]
  • 19. Gardner P. A. and Albright A. L., ““Like Mother, Like Son”: Hereditary Anterior Sacral Meningocele. Case Report and Review of the Literature,” Journal of Neurosurgery 104, no. Suppl 2 (2006): 138–142. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

The data that support the findings of this study are available from the corresponding author upon reasonable request.


Articles from Congenital Anomalies are provided here courtesy of Wiley

RESOURCES